#

Novo Nordisk

: 101
Novo Nordisk shares rise after approval of Wegovy to treat liver disease
News·
Novo Nordisk shares rise after approval of Wegovy to treat liver disease
Morning in New York: keeping a balance in the news flow
News·
Morning in New York: keeping a balance in the news flow
Vismas listing in London and Bullishs success in New York: highlights of the IPO by August 17
News·
Visma's listing in London and Bullish's success in New York: highlights of the IPO by August 17
Eli Lilly has disappointed with the outcome of a weight loss pill trial. Shares are down 15%
News·
Eli Lilly has disappointed with the outcome of a weight loss pill trial. Shares are down 15%
The Novo Nordisk case: how the creator of Ozempic lost leadership in the market it created
Review·
The Novo Nordisk case: how the creator of Ozempic lost leadership in the market it created
Shares of telehealth company LifeMD in free fall after 2025 guidance downgraded
Small Caps·
Shares of telehealth company LifeMD in free fall after 2025 guidance downgraded
Sales of the drug Wegovy increased by 67%. Will this convince Novo Nordisk investors?
News·
Sales of the drug Wegovy increased by 67%. Will this convince Novo Nordisk investors?
Morning in New York: political agenda sets the vector for trading
News·
Morning in New York: political agenda sets the vector for trading
UBS no longer advises buying shares in the maker of Ozempic. Is it inferior to a competitor?
News·
UBS no longer advises buying shares in the maker of Ozempic. Is it inferior to a competitor?
Hims & Hers proclaimed an exciting period of growth. Why did the stock collapse?
News·
Hims & Hers proclaimed an "exciting period of growth". Why did the stock collapse?
Disney, Palantir and Novo Nordisk reports: what investors need to know this week
News·
Disney, Palantir and Novo Nordisk reports: what investors need to know this week
Stoxx 600 at its lowest in a month, US futures fall: markets react to duties
News·
Stoxx 600 at its lowest in a month, US futures fall: markets react to duties
Load more